The findings confirm that allosteric inhibition of integrase is clinically viable, validating a new antiviral drug class.

There’s been a lot of grim news lately about HIV and AIDS: Rising infections among high-risk U.S. communities, continued risk behaviors, and plague-level infection rates across sub-Saharan Africa. In ...

A federal grant for HIV research is part of $15.7 million the National Institutes for Health awarded to the Wertheim UF ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...

Gilead has developed a 1-every-6-month injection to prevent HIV. The medication will sell for $14,000 a shot. With numerous proposed major cuts to Medicaid and the Affordable Care Act in congress, ...

More than 40 drugs are now available to treat HIV infection Medically reviewed by Lindsay Cook, PharmD Fact checked by Sarah ...

Scientists at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology in Jupiter have received $15.7 million in four separate federal grants to help with their research over ...